The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia, RJ Vassar - Molecular neurodegeneration, 2023 - Springer
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

G Livingston, J Huntley, A Sommerlad, D Ames… - The lancet, 2020 - thelancet.com
Executive summary The number of older people, including those living with dementia, is
rising, as younger age mortality declines. However, the age-specific incidence of dementia …

Association of sleep duration in middle and old age with incidence of dementia

S Sabia, A Fayosse, J Dumurgier, VT van Hees… - Nature …, 2021 - nature.com
Sleep dysregulation is a feature of dementia but it remains unclear whether sleep duration
prior to old age is associated with dementia incidence. Using data from 7959 participants of …

Circadian rhythm as a therapeutic target

W Ruan, X Yuan, HK Eltzschig - Nature Reviews Drug Discovery, 2021 - nature.com
The circadian clock evolved in diverse organisms to integrate external environmental
changes and internal physiology. The clock endows the host with temporal precision and …

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

G Livingston, J Huntley, KY Liu, SG Costafreda… - The Lancet, 2024 - thelancet.com
Executive summary The 2024 update of the Lancet Commission on dementia provides new
hopeful evidence about dementia prevention, intervention, and care. As people live longer …

Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors

C Wang, DM Holtzman - Neuropsychopharmacology, 2020 - nature.com
As we age, we experience changes in our nighttime sleep and daytime wakefulness.
Individuals afflicted with Alzheimer's disease (AD) can develop sleep problems even before …

Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease

NM Lyra e Silva, RA Gonçalves, TA Pascoal… - Translational …, 2021 - nature.com
Alzheimer's disease (AD) is associated with memory impairment and altered peripheral
metabolism. Mounting evidence indicates that abnormal signaling in a brain-periphery …

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

N Zisapel - British journal of pharmacology, 2018 - Wiley Online Library
In mammals, a central circadian clock, located in the suprachiasmatic nuclei (SCN) of the
hypothalamus, tunes the innate circadian physiological rhythms to the ambient 24 h light …

Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment

AH Meghdadi, M Stevanović Karić, M McConnell… - PloS one, 2021 - journals.plos.org
In this paper, we explore the utility of resting-state EEG measures as potential biomarkers for
the detection and assessment of cognitive decline in mild cognitive impairment (MCI) and …

[HTML][HTML] Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need

GM Babulal, YT Quiroz, BC Albensi… - Alzheimer's & …, 2019 - Elsevier
Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging
population and society as a whole. With the numbers of people with ADRDs predicted to rise …